A lung-specific neo-antigen elicits specific CD8+ T cell tolerance with preserved CD4+ T cell reactivity. Implications for immune-mediated lung disease.
about
Influenza lung injury: mechanisms and therapeutic opportunitiesPerforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition.Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation.CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.Preferential migration of effector CD8+ T cells into the interstitium of the normal lung.Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease.Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors.Interference with intraepithelial TNF-α signaling inhibits CD8(+) T-cell-mediated lung injury in influenza infectionImpairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection.Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury.Structural requirements for intracellular targeting of SP-C proprotein.CpG-ODN Facilitates Effective Intratracheal Immunization and Recall of Memory against Neoantigen-Expressing Alveolar Cells.CD8(+) T cells responding to alveolar self-antigen lack CD25 expression and fail to precipitate autoimmunity.Human surfactant protein B promoter in transgenic mice: temporal, spatial, and stimulus-responsive regulation.
P2860
Q28083505-35779F1D-6457-48AA-8320-B141F632B351Q30303947-88EE1BD3-89C2-47FC-BCE1-F1F0EF1B2FB8Q30306117-57FB5729-829F-4E15-907E-EC0742693414Q30308011-704B07CF-F034-4D24-93E2-F071E6B3DCD6Q30308384-9281F7BD-353D-455A-B375-B5A1697B3215Q30438791-F8C90199-283E-4931-8E97-BD892A41D94DQ30448788-AA5784AB-2812-41A5-B4DF-D6D52AFB093AQ33999909-F0A9C2FA-B798-48DA-B14B-577605A352E4Q34347141-558815C3-E1EF-4BB4-B13F-B9E7884D7E7DQ36922079-601A0461-B835-4184-B03A-C3C0110FDE00Q37455704-99FBA8B5-22C7-43CF-96B7-70E7B4C0B3CAQ40917719-6B3A79A2-9A8E-41CF-8877-BF1B028971D5Q42371892-B76762BA-93C7-4865-A496-E7455BA09DBFQ44580235-8747EB8B-2930-4607-9885-66E05408EE9AQ52124036-681E3515-7D41-4222-9590-388D3B88DE1C
P2860
A lung-specific neo-antigen elicits specific CD8+ T cell tolerance with preserved CD4+ T cell reactivity. Implications for immune-mediated lung disease.
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
A lung-specific neo-antigen el ...... immune-mediated lung disease.
@ast
A lung-specific neo-antigen el ...... immune-mediated lung disease.
@en
type
label
A lung-specific neo-antigen el ...... immune-mediated lung disease.
@ast
A lung-specific neo-antigen el ...... immune-mediated lung disease.
@en
prefLabel
A lung-specific neo-antigen el ...... immune-mediated lung disease.
@ast
A lung-specific neo-antigen el ...... immune-mediated lung disease.
@en
P2093
P2860
P356
P1476
A lung-specific neo-antigen el ...... immune-mediated lung disease.
@en
P2093
A Srikiatkhachorn
C Kerlakian
J A Whitsett
M H Stoler
R I Enelow
S Agersborg
T J Braciale
P2860
P304
P356
10.1172/JCI118874
P407
P577
1996-08-01T00:00:00Z